UnknownPhase 3

Effects of Aspirin and Low Molecular Weight Heparin in IVF Outcome.

India400 participantsStarted 2013-08

Plain-language summary

The purpose of the study is to determine whether low-dose aspirin and low molecular weight heparin improve the implantation and pregnancy rates in patients with repeated implantation failures in IVF cycle.

Who can participate

Age range19 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged between 19 to 35 years; * Basal follicle-stimulating hormone (FSH) levels of ≤8 IU/l * Body mass index (BMI) between 19 kg/m2 and 25 kg/m2 * Presence of both ovaries; ≥2 previous IVF failures * Good quality embryos for transfer * Endometrial thickness between 10 mm and 14 mm Exclusion Criteria: * Polycystic ovary syndrome * Endometriosis

What they're measuring

Biological pregnancy test

Timeframe: 14 days

Trial details

NCT IDNCT01924104

SponsorDr.Vandana Bansal

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-08

Contact for this trial

Vandana Bansal, MS DGO PhD

+91-0532-2417252 bansal.drvandana@gmail.com

View on ClinicalTrials.gov More To Investigate the Effects of Low Dose Aspirin and Low Molecular Weight Heparin in IVF Out Come trials